Correspondence on 'Disease activity, cytokines, chemokines and the risk of incident diabetes in rheumatoid arthritis'

Piero Ruscitti¹, Giorgio Sesti², Paola Cipriani³, Roberto Gerli⁴, Roberto Giacomelli⁵

Affiliations

¹ Department of Clinical Sciences and Applied Biotechnology, University of L'Aquila, L'Aquila, Abruzzo, Italy piero.ruscitti@univaq.it.
² Department of Clinical and Molecular Medicine, Sapienza University of Rome, Roma, Lazio, Italy.
³ Department of Clinical Sciences and Applied Biotechnology, University of L'Aquila, L'Aquila, Abruzzo, Italy.
⁴ Rheumatology Unit, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
⁵ Unit of Allergology, Immunology, Rheumatology, Department of Medicine, Università Campus Bio-Medico di Roma, Rome, Italy.

PMID: 33619161
DOI: 10.1136/annrheumdis-2021-220047

Free article

Comment

Correspondence on 'Disease activity, cytokines, chemokines and the risk of incident diabetes in rheumatoid arthritis'

Piero Ruscitti et al. Ann Rheum Dis. 2023 May.

Free article

. 2023 May;82(5):e119.

doi: 10.1136/annrheumdis-2021-220047. Epub 2021 Feb 22.

Authors

Piero Ruscitti¹, Giorgio Sesti², Paola Cipriani³, Roberto Gerli⁴, Roberto Giacomelli⁵

Affiliations

¹ Department of Clinical Sciences and Applied Biotechnology, University of L'Aquila, L'Aquila, Abruzzo, Italy piero.ruscitti@univaq.it.
² Department of Clinical and Molecular Medicine, Sapienza University of Rome, Roma, Lazio, Italy.
³ Department of Clinical Sciences and Applied Biotechnology, University of L'Aquila, L'Aquila, Abruzzo, Italy.
⁴ Rheumatology Unit, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
⁵ Unit of Allergology, Immunology, Rheumatology, Department of Medicine, Università Campus Bio-Medico di Roma, Rome, Italy.

PMID: 33619161
DOI: 10.1136/annrheumdis-2021-220047

No abstract available

Keywords: arthritis; biological therapy; interleukin 1 receptor antagonist protein; rheumatoid.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Comment in

Response to: 'Correspondence on 'Disease activity, cytokines, chemokines and the risk of incident diabetes in rheumatoid arthritis'' by Ruscitti et al.
Baker JF, England BR, Mikuls TR. Baker JF, et al. Ann Rheum Dis. 2023 May;82(5):e120. doi: 10.1136/annrheumdis-2021-220114. Epub 2021 Feb 22. Ann Rheum Dis. 2023. PMID: 33619163 No abstract available.

Comment on

Disease activity, cytokines, chemokines and the risk of incident diabetes in rheumatoid arthritis.
Baker JF, England BR, George M, Cannon G, Sauer B, Ogdie A, Hamilton BC, Hunter C, Duryee MJ, Thiele G, Mikuls TR. Baker JF, et al. Ann Rheum Dis. 2021 May;80(5):566-572. doi: 10.1136/annrheumdis-2020-219140. Epub 2021 Jan 4. Ann Rheum Dis. 2021. PMID: 33397733 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Correspondence on 'Disease activity, cytokines, chemokines and the risk of incident diabetes in rheumatoid arthritis'

Affiliations

Correspondence on 'Disease activity, cytokines, chemokines and the risk of incident diabetes in rheumatoid arthritis'

Authors

Affiliations

Conflict of interest statement

Comment in

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical